Growth-hormone-releasing hormone analog
CJC-1295 (no DAC)
Also known as Modified GRF (1-29)
A short-acting GHRH analog (no drug-affinity complex) frequently paired with a GHS in growth-axis research.
CJC-1295 without DAC is a modified GRF(1-29) analog that stimulates the growth-hormone-releasing-hormone receptor. The 'no DAC' form is short-acting and is commonly studied alongside a growth-hormone secretagogue such as ipamorelin to examine synergistic GH-pulse profiles.
Common research areas
- GHRH-receptor activation
- GHRH + GHS combination research
- GH-axis signaling studies
Watch
CJC-1295 + Ipamorelin: The Classic Stack
Dr. Ashley FroeseYouTube ↗
In our catalog
CJC-1295 No DAC 10 mg · $80 CAD · ≥99.3% HPLC
Related compounds
Further reading
Selected references
- 1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GHRH analog. J Clin Endocrinol Metab, 2006. PMID 16352683
- 2. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal, 2022. PMID 34665524
- 3. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse, 2016. PMID 26771670
For laboratory research use only. Reference information, not usage guidance or dosing advice.